Summary
Dihydropyrimidine dehydrogenase (DPD) deficiency (McKusick 274270) is a clinically heterogeneous autosomal recessive disorder of pyrimidine metabolism. DPD is the enzyme that catalyses the first and the rate-limiting step in the catabolism of uracil, thymine and the analogue 5-fluorouracil. To date, more than 30 patients have been diagnosed with a complete enzyme deficiency. Here, we describe the fifth case with a complete DPD deficiency presenting at birth with severe neurological abnormalities. The patient was homozygous for the common splice-site mutation IVS14+1G > A.
This is a preview of subscription content, log in via an institution to check access.
References
Bakker HD, Rubio Gozalbo ME, Van Gennip AH (1994) Dihydropyrimidine dehydrogenase deficiency presenting with psychomotor retardation and ocular abnormalities. J Inherit Metab Dis 17: 640–641.
Van Kuilenburg ABP, Vreken P, Abeling NG, et al (1999a) Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet 104: 1–9.
Van Kuilenburg ABP, Vreken P, Riva D, et al (1999b) Clinical and biochemical abnormalities in a patient with dihydropyrimidine dehydrogenease deficiency due to homozygosity for C29R mutation. J Inherit Metab Dis 22: 191–192.
Wadman SK, Berger R, Duran M, et al (1985) Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism. J Inherit Metab Dis 8(Supplement 2): 113–114.
Wilcken B, Hammond J, Berger R, Wise G, James C (1985) Dihydropyrimidine dehydrogenase deficiency—a further case. J Inherit Metab Dis 8(Supplement 2): 115–116.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Sanna’a, N.A., Van Kuilenburg, A.B.P., Atrak, T.M. et al. Dihydropyrimidine dehydrogenase deficiency presenting at birth. J Inherit Metab Dis 28, 793–796 (2005). https://doi.org/10.1007/s10545-005-4218-0
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-4218-0